Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Potential of fidarestat in diabetic retinopathy emerges from preclinical studies

Sep. 4, 2002

Once-weekly risedronate approved in Sweden

Sep. 4, 2002

Ezetimibe + statins consistently better than statin therapy alone

Sep. 4, 2002

Orally active LH receptor agonist with efficacy in inducing ovulation in mice

Sep. 4, 2002

AERx iDMS enters phase III program

Sep. 4, 2002

NNC-25-2504: a glucagon antagonist that inhibits hepatic glucose production

Sep. 3, 2002

Long-acting DAC:GLP-1 analogue effective and well tolerated in preclinical studies

Sep. 3, 2002

Different effects of thiazolidinediones on adipogenesis

Sep. 3, 2002

Reductions in liver lipid content on BMS-298585 in rodents fed high-fat diets

Sep. 3, 2002

Merck & Co. presents growth hormone-secreting compounds at ACS

Sep. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...